(Stroke. 1997;28:557-563.)
© 1997 American Heart Association, Inc.
Articles |
Serum Creatinine Concentration and Risk of Cardiovascular Disease
A Possible Marker for Increased Risk of Stroke
From the Department of Primary Care and Population Sciences, Royal Free Hospital School of Medicine, London, UK.
Correspondence to Dr S. Goya Wannamethee, Department of Primary Care and Population Sciences, Royal Free Hospital School of Medicine, Rowland Hill St, London, NW3 2PF, UK.
Background and Purpose Elevated serum creatinine has been associated with increased mortality in hypertensive persons, the elderly, and patients with myocardial infarction or stroke in whom cardiovascular disease is the major cause of death. We have examined the relationship between serum creatinine concentration and the risk of major ischemic heart disease and stroke events and all-cause mortality in a general population of middle-aged men.
Methods We present a prospective study of middle-aged men (aged 40 to 59 years) drawn from 24 British towns who have been followed up for an average of 14.75 years. Data on serum creatinine were available for 7690 men in whom there were 287 major stroke events, 967 major ischemic heart disease events, and 1259 deaths from all causes during follow-up.
Results The median serum creatinine concentration was
98 µmol/L (95% range, 76 to 129 µmol/L). Stroke risk was
significantly increased at levels above 116 µmol/L (90th
percentile) even after adjustment for a wide range of cardiovascular
risk factors (relative risk [RR], 1.6; 95% CI, 1.1 to 2.1;
116 µmol/L versus the rest). Risk of a major ischemic
heart disease event was significantly increased at or above 130
µmol/L (97.5 percentile), but this was attenuated after adjustment
(RR, 1.2; 95% CI, 0.8 to 1.7; 130 µmol/L versus the rest).
There was a weak but significant positive association between diastolic
blood pressure and creatinine concentration. However, elevated
creatinine concentration (116 µmol/L) was associated with a
significant increase in stroke in both normotensive and hypertensive
men. All-cause mortality and overall cardiovascular mortality were
significantly increased only above the 97.5 percentile, and no
significant association was seen with cancer or other noncardiovascular
mortality.
Conclusions A high serum creatinine concentration within the normal range is a marker for increased risk of cerebrovascular disease in both normotensive and hypertensive subjects. These findings support the evidence indicating that subtle impairment of renal function is a factor for increased risk of stroke and suggest mechanisms in the pathogenesis of stroke that warrant further investigation.
Key Words: cardiovascular disorders • creatinine • mortality • risk factors
This article has been cited by other articles:
 |
|
 |
|
  H. Kastarinen, O. Ukkola, and Y. A. Kesaniemi Glomerular filtration rate is related to carotid intima-media thickness in middle-aged adults Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2767 - 2772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Go, M. C. Fang, N. Udaltsova, Y. Chang, N. K. Pomernacki, L. Borowsky, D. E. Singer, and for the ATRIA Study Investigators Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study Circulation, March 17, 2009; 119(10): 1363 - 1369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kobayashi, N. Hirawa, K. Yatsu, Y. Kobayashi, Y. Yamamoto, S. Saka, D. Andoh, Y. Toya, G. Yasuda, and S. Umemura Relationship between silent brain infarction and chronic kidney disease Nephrol. Dial. Transplant., January 1, 2009; 24(1): 201 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tsagalis, T. Akrivos, M. Alevizaki, E. Manios, K. Stamatellopoulos, A. Laggouranis, and K. N. Vemmos Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality Nephrol. Dial. Transplant., January 1, 2009; 24(1): 194 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Lyrer, F. Fluri, D. Gisler, S. Papa, F. Hatz, and S. T. Engelter Renal function and outcome among stroke patients treated with IV thrombolysis Neurology, November 4, 2008; 71(19): 1548 - 1550. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sander, K. Sander, and H. Poppert Review: Stroke in type 2 diabetes The British Journal of Diabetes & Vascular Disease, September 1, 2008; 8(5): 222 - 229. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Ovbiagele Impairment in Glomerular Filtration Rate or Glomerular Filtration Barrier and Occurrence of Stroke Arch Neurol, July 1, 2008; 65(7): 934 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cirillo, M. P. Lanti, A. Menotti, M. Laurenzi, M. Mancini, A. Zanchetti, and N. G. De Santo Definition of Kidney Dysfunction as a Cardiovascular Risk Factor: Use of Urinary Albumin Excretion and Estimated Glomerular Filtration Rate Arch Intern Med, March 24, 2008; 168(6): 617 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Seliger and W.T. Longstreth Jr Lessons About Brain Vascular Disease From Another Pulsating Organ, the Kidney Stroke, January 1, 2008; 39(1): 5 - 6. [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Townsend Stroke in Chronic Kidney Disease: Prevention and Management Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(Supplement_1): S11 - S16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Khatri, C. B. Wright, T. L. Nickolas, M. Yoshita, M. C. Paik, G. Kranwinkel, R. L. Sacco, and C. DeCarli Chronic Kidney Disease Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study (NOMAS) Stroke, December 1, 2007; 38(12): 3121 - 3126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. T. Raymond, D. Zehnder, S. C. H. Smith, J. A. Stinson, H. Lehnert, and R. M. Higgins Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3214 - 3220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. E. Hirai, S. E. Moss, M. D. Knudtson, B. E. K. Klein, and R. Klein Retinopathy and Survival in a Population without Diabetes: The Beaver Dam Eye Study Am. J. Epidemiol., September 15, 2007; 166(6): 724 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A.A. Fox, J.-P. Bassand, S. R. Mehta, L. Wallentin, P. Theroux, L. S. Piegas, V. Valentin, T. Moccetti, S. Chrolavicius, R. Afzal, et al. Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non-ST-Segment Elevation Acute Coronary Syndromes Ann Intern Med, September 4, 2007; 147(5): 304 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Glynn, D. Reddan, J. Newell, J. Hinde, B. Buckley, and A. W. Murphy Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-based cohort study Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2586 - 2594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Daly Is early chronic kidney disease an important risk factor for cardiovascular disease?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_9): ix19 - ix25. [Full Text] [PDF]
|
|
|
|
|
|
P. A. McCullough, C. T. Jurkovitz, P. E. Pergola, J. B. McGill, W. W. Brown, A. J. Collins, S.-C. Chen, S. Li, A. Singh, K. C. Norris, et al. Independent Components of Chronic Kidney Disease as a Cardiovascular Risk State: Results From the Kidney Early Evaluation Program (KEEP) Arch Intern Med, June 11, 2007; 167(11): 1122 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Shadman, M. A. Allison, and M. H. Criqui Glomerular Filtration Rate and N-Terminal Pro-Brain Natriuretic Peptide as Predictors of Cardiovascular Mortality in Vascular Patients J. Am. Coll. Cardiol., June 5, 2007; 49(22): 2172 - 2181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Weiner, H. Tighiouart, A. S. Levey, E. Elsayed, J. L. Griffith, D. N. Salem, and M. J. Sarnak Lowest Systolic Blood Pressure Is Associated with Stroke in Stages 3 to 4 Chronic Kidney Disease J. Am. Soc. Nephrol., March 1, 2007; 18(3): 960 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Sarafidis and G. L. Bakris Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2366 - 2374. [Full Text] [PDF]
|
|
|
|
|
|
N. Koren-Morag, U. Goldbourt, and D. Tanne Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology, July 25, 2006; 67(2): 224 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tonelli, N. Wiebe, B. Culleton, A. House, C. Rabbat, M. Fok, F. McAlister, and A. X. Garg Chronic Kidney Disease and Mortality Risk: A Systematic Review J. Am. Soc. Nephrol., July 1, 2006; 17(7): 2034 - 2047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Meisinger, A. Doring, H. Lowel, and for the KORA Study Group Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population Eur. Heart J., May 2, 2006; 27(10): 1245 - 1250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Seliger, W.T. Longstreth Jr, R. Katz, T. Manolio, L. F. Fried, M. Shlipak, C. O. Stehman-Breen, A. Newman, M. Sarnak, D. L. Gillen, et al. Cystatin C and Subclinical Brain Infarction J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3721 - 3727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Vanholder, Z. Massy, A. Argiles, G. Spasovski, F. Verbeke, N. Lameire, and for the European Uremic Toxin Work Group (EUTox) Chronic kidney disease as cause of cardiovascular morbidity and mortality Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1048 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. de Leeuw, L. M. Ruilope, C. R. Palmer, M. J. Brown, A. Castaigne, G. Mancia, T. Rosenthal, and G. Wagener Clinical Significance of Renal Function in Hypertensive Patients at High Risk: Results From the INSIGHT Trial Arch Intern Med, December 13, 2004; 164(22): 2459 - 2464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch, and C.-y. Hsu Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization N. Engl. J. Med., September 23, 2004; 351(13): 1296 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Seliger, D. S. Siscovick, C. O. Stehman-Breen, D. L. Gillen, A. Fitzpatrick, A. Bleyer, and L. H. Kuller Moderate Renal Impairment and Risk of Dementia among Older Adults: The Cardiovascular Health Cognition Study J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1904 - 1911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Andrews Review: Renal dysfunction as a marker of increased vascular risk The British Journal of Diabetes & Vascular Disease, May 1, 2004; 4(3): 152 - 155. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Arboix, M. Tarruella, L. Garcia-Eroles, M. Oliveres, C. Miquel, M. Balcells, and C. Targa Ischemic stroke in patients with intermittent claudication: a clinical study of 142 cases Vascular Medicine, February 1, 2004; 9(1): 13 - 17. [Abstract] [PDF]
|
|
|
|
|
|
S. D. Roger, L. P. McMahon, A. Clarkson, A. Disney, D. Harris, C. Hawley, H. Healy, P. Kerr, K. Lynn, A. Parnham, et al. Effects of Early and Late Intervention with Epoetin {alpha} on Left Ventricular Mass among Patients with Chronic Kidney Disease (Stage 3 or 4): Results of a Randomized Clinical Trial J. Am. Soc. Nephrol., January 1, 2004; 15(1): 148 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension, November 1, 2003; 42(5): 1050 - 1065. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation, October 28, 2003; 108(17): 2154 - 2169. [Full Text] [PDF]
|
|
|
|
 |
|
 G. D'Ancona, J. I. S. de Ibarra, R. Baillot, P. Mathieu, D. Doyle, J. Metras, D. Desaulniers, and F. Dagenais Determinants of stroke after coronary artery bypass grafting Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 552 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J J Santopinto, K A A Fox, R J Goldberg, A Budaj, G Pinero, A Avezum, D Gulba, J Esteban, J M Gore, J Johnson, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE) Heart, September 1, 2003; 89(9): 1003 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Ohmit, J. M. Flack, R. M. Peters, W. W. Brown, and R. Grimm Longitudinal Study of the National Kidney Foundation's (NKF) Kidney Early Evaluation Program (KEEP) J. Am. Soc. Nephrol., July 1, 2003; 14(90002): S117 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Chadban, E. M. Briganti, P. G. Kerr, D. W. Dunstan, T. A. Welborn, P. Z. Zimmet, and R. C. Atkins Prevalence of Kidney Damage in Australian Adults: The AusDiab Kidney Study J. Am. Soc. Nephrol., July 1, 2003; 14(90002): S131 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Freeman, R. H. Mehta, W. Al Badr, J. V. Cooper, E. Kline-Rogers, and K. A. Eagle Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors J. Am. Coll. Cardiol., March 5, 2003; 41(5): 718 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.L. Hillege, W.H. van Gilst, D.J. van Veldhuisen, G. Navis, D.E. Grobbee, P.A. de Graeff, and D. de Zeeuw Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial Eur. Heart J., March 1, 2003; 24(5): 412 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.T. Longstreth Jr, C. Dulberg, T. A. Manolio, M. R. Lewis, N. J. Beauchamp Jr, D. O'Leary, J. Carr, and C. D. Furberg Incidence, Manifestations, and Predictors of Brain Infarcts Defined by Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study Stroke, October 1, 2002; 33(10): 2376 - 2382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. de Leeuw, L. Thijs, W. H. Birkenhager, S. M. Voyaki, A. D. Efstratopoulos, R. H. Fagard, G. Leonetti, C. Nachev, J. C. Petrie, J. L. Rodicio, et al. Prognostic Significance of Renal Function in Elderly Patients with Isolated Systolic Hypertension: Results from the Syst-Eur Trial J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2213 - 2222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ascione, B. C. Reeves, M. H. Chamberlain, A. K. Ghosh, K. H.H. Lim, and G. D. Angelini Predictors of stroke in the modern era of coronary artery bypass grafting: a case control study Ann. Thorac. Surg., August 1, 2002; 74(2): 474 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.R. Sorensen, B. Brendorp, C. Rask-Madsen, L. Kober, E. Kjoller, and C. Torp-Pedersen The prognostic importance of creatinine clearance after acute myocardial infarction Eur. Heart J., June 2, 2002; 23(12): 948 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. MacWalter, S. Y.S. Wong, K. Y.K. Wong, G. Stewart, C. G. Fraser, H. W. Fraser, Y. Ersoy, S. A. Ogston, and R. Chen Does Renal Dysfunction Predict Mortality After Acute Stroke?: A 7-Year Follow-Up Study Stroke, June 1, 2002; 33(6): 1630 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Shlipak, J. A. Simon, D. Grady, F. Lin, N. K. Wenger, C. D. Furberg, and for the Heart and Estrogen/progestin Replacement S Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease J. Am. Coll. Cardiol., September 1, 2001; 38(3): 705 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J Pocock, V. McCormack, F. Gueyffier, F. Boutitie, R. H Fagard, and J.-P. Boissel A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials BMJ, July 14, 2001; 323(7304): 75 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F.E. Mann, H. C. Gerstein, J. Pogue, J. Bosch, S. Yusuf, and for the HOPE Investigators Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial Ann Intern Med, April 17, 2001; 134(8): 629 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Kasiske The Kidney in Cardiovascular Disease Ann Intern Med, April 17, 2001; 134(8): 707 - 709. [Full Text] [PDF]
|
|
|
|
|
|
J.-G. Wang, J. A. Staessen, R. H. Fagard, W. H. Birkenhager, L. Gong, and L. Liu Prognostic Significance of Serum Creatinine and Uric Acid in Older Chinese Patients With Isolated Systolic Hypertension Hypertension, April 1, 2001; 37(4): 1069 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. McCullough, S. S. Soman, S. S. Shah, S. T. Smith, K. R. Marks, J. Yee, and S. Borzak Risks associated with renal dysfunction in patients in the coronary care unit J. Am. Coll. Cardiol., September 1, 2000; 36(3): 679 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Makino, Y. Kawano, J. Minami, T. Yamaguchi, and S. Takishita Risk of Stroke in Relation to Level of Blood Pressure and Other Risk Factors in Treated Hypertensive Patients Stroke, January 1, 2000; 31(1): 48 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. T. Longstreth Jr, C. Bernick, T. A. Manolio, N. Bryan, C. A. Jungreis, T. R. Price, and for the Cardiovascular Health Study Collaborative Lacunar Infarcts Defined by Magnetic Resonance Imaging of 3660 Elderly People: The Cardiovascular Health Study Arch Neurol, September 1, 1998; 55(9): 1217 - 1225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mattana, C. Effiong, R. Gooneratne, and P. C. Singhal Outcome of Stroke in Patients Undergoing Hemodialysis Arch Intern Med, March 9, 1998; 158(5): 537 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mosca, J. E. Manson, S. E. Sutherland, R. D. Langer, T. Manolio, E. Barrett-Connor, and E. Barrett-Connor Cardiovascular Disease in Women : A Statement for Healthcare Professionals From the American Heart Association Circulation, October 7, 1997; 96(7): 2468 - 2482. [Full Text]
|
|